Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sivelestat sodium for perioperative acute lung injury in cardiac surgery
ChiCTR2300074438Phase 4Recruiting
- Sponsor
- Fujian Medical University Union Hospital
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of sivelestat in acute lung injury (ALI) (2 arms), sponsored by Fujian Medical University Union Hospital. Primary endpoints: Inflammatory factor levels, Expression of miR-503 and DUSP1 genes and 2 more. Started Jul 2023; status: recruiting.
02
Drugs
sivelestat
03
Conditions
acute lung injury (ALI)
Beyond the preview
Go deeper on ChiCTR2300074438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074438.